A detailed history of Geode Capital Management, LLC transactions in Absci Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,933,593 shares of ABSI stock, worth $5.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,933,593
Previous 1,809,697 6.85%
Holding current value
$5.78 Million
Previous $5.57 Million 32.53%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.97 - $4.49 $367,971 - $556,293
123,896 Added 6.85%
1,933,593 $7.39 Million
Q2 2024

Aug 09, 2024

BUY
$2.92 - $6.58 $3.28 Million - $7.39 Million
1,123,538 Added 163.74%
1,809,697 $5.57 Million
Q1 2024

May 13, 2024

BUY
$3.41 - $5.74 $80,059 - $134,763
23,478 Added 3.54%
686,159 $3.9 Million
Q4 2023

Feb 13, 2024

BUY
$1.15 - $4.79 $107,539 - $447,927
93,513 Added 16.43%
662,681 $2.78 Million
Q3 2023

Nov 13, 2023

BUY
$1.28 - $2.41 $153,276 - $288,590
119,747 Added 26.64%
569,168 $751,000
Q2 2023

Aug 11, 2023

SELL
$1.17 - $2.03 $540,735 - $938,199
-462,167 Reduced 50.7%
449,421 $683,000
Q1 2023

May 15, 2023

SELL
$1.58 - $3.41 $56,687 - $122,343
-35,878 Reduced 3.79%
911,588 $1.6 Million
Q4 2022

Feb 13, 2023

BUY
$2.0 - $3.58 $1,574 - $2,817
787 Added 0.08%
947,466 $1.99 Million
Q3 2022

Nov 14, 2022

BUY
$2.95 - $4.83 $857,624 - $1.4 Million
290,720 Added 44.32%
946,679 $2.96 Million
Q2 2022

Aug 12, 2022

BUY
$3.13 - $8.83 $60,033 - $169,359
19,180 Added 3.01%
655,959 $2.18 Million
Q1 2022

May 13, 2022

BUY
$5.87 - $9.46 $2.07 Million - $3.33 Million
352,327 Added 123.86%
636,779 $5.37 Million
Q4 2021

Feb 11, 2022

BUY
$7.88 - $18.03 $717,529 - $1.64 Million
91,057 Added 47.08%
284,452 $2.33 Million
Q3 2021

Nov 12, 2021

BUY
$10.37 - $30.29 $2.01 Million - $5.86 Million
193,395 New
193,395 $2.25 Million

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $278M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.